Evaxion A/S(EVAX)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings.

Evaxion A/S (EVAX) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores EVAX at 32.7/100 on a 32-signal composite quality model, placing it at rank #2,413 of 2,962 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (FY 2025), Evaxion A/S reports quarterly revenue of $7.5M, net income of $-7.7M. Top institutional holders of EVAX by reported 13-F value include Merck, Ikarian Capital, Rathbones Group PLC, based on the most recent SEC filings. EVAX trades on the Nasdaq exchange and files with the SEC under CIK 1828253. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate EVAX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Evaxion A/S directly from SEC EDGAR.